Abstract: An absorbable surgical suture material based on monocarboxycellulose having the general formula ##STR1## where: m is a degree of polymerization of the initial cellulose from 250 to 3,300;p is a molar fraction of D-glucopyranose cycles in one polymer period from 0.95 to 0.05;q is a molar fraction of cycles of d-anhydroglucuronic acid from 0.05 to 0.95;S is a molar fraction of the complex fragment of D-anhydroglucuronic acid, metal, and ligand from 0.03 to 0.55;Me is a transition metal;n is a valence of the transition metal;k is a coordination number of the transition metal .gtoreq.4;Lig is polydentate ligands;Dent is a dentation of the ligands .gtoreq.2.A method for producing said material consists in that cellulose threads are first threaded with nitrogen oxides, then for 0.5 to 2.0 hours treated with a 0.5-2.0-percent solution of a salt of a transition metal with a coordination number not less than 4 in a suitable solvent, and after this treated for 0.5 to 2.0 hours with a 1.0-2.

Abstract: According to the invention, the novel substances are the cardenolide and adienolide derivatives of ajmaline of the general formula ##STR1## wherein R is cardenolide or bufadienolide of the general formula ##STR2## Z is an unsaturated five-member or six-member lactone ring of the general formula ##STR3## y' is a radical --CH.sub.3, or --CHO; y" is H or OH,X is a halogen.According to the present invention, the process for producing the cardenolide or bufadienolide derivatives of ajmaline resides in that cardenolide or bufadienolide is reacted with acid halides in a medium of an organic solvent, which does not react with organic acid anhydrides, at a temperature of -10.degree. to +25.degree. C., and added to the thus-obtained halide of cardenolide or bufadienolide is ajmaline in a medium of said organic solvent, followed by isolation of the end product.

Abstract: A medicinal preparation with an antiinflammatory, analgesic and antipyretic effect, comprising 2,2,2-trichloro-1-(2-thiazolyl amino)-ethanol as the active principle, which has the following formula: ##STR1## and an appropriate pharmaceutical carrier. The preparation is used for the treatment of various diseases, for example: rheumatism in the active phase, rheumatoid, infectious allergic and metabolic arthritis, spondyloses and arthroses, lumbosacral radiculitis, and others.